Physician profile
Lindalee Smith
NPI 1386004042
$1,939.36
in general payments reported to CMS, 2019-2025
18 companies · $249 in 2025
The $249 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,051 · 2022: $462 · 2023: $178 · 2025: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $401.21 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $302.08 | 2021-2023 | Verquvo |
| Amgen INC. | $173.60 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $166.30 | 2021 | |
| Abbott Laboratories | $154.49 | 2025 | Mitraclip |
| Astrazeneca Pharmaceuticals LP | $148.81 | 2021-2025 | Farxiga |
| Abiomed | $117.96 | 2021 | |
| Medtronic, INC. | $110.05 | 2021 | |
| Novartis Pharmaceuticals Corporation | $87.83 | 2021-2022 | |
| Pfizer INC. | $50.45 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.24 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $45.00 | 2021-2022 | |
| United Therapeutics Corporation | $38.79 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $32.39 | 2021 | |
| Biotronik INC. | $18.92 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.91 | 2021 | |
| Althera Pharmaceuticals LLC | $14.92 | 2022 | |
| Amarin Pharma, INC. | $13.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindalee Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.